Brevibloc Premixed

Brevibloc Premixed contains Esmolol Hydrochloride, a beta-blocker used for intravenous administration. It is commonly used to manage rapid heart rates and control blood pressure during surgical procedures.

Brevibloc Premixed is primarily used for the rapid control of heart rate and blood pressure. It is often administered intravenously to manage conditions such as supraventricular tachycardia and to control heart rate during surgery. Esmolol Hydrochloride works by blocking beta-adrenergic receptors, which helps to slow the heart rate and reduce the force of heart contractions.

Common effects of Brevibloc Premixed may include a decrease in heart rate and blood pressure. Some individuals might experience temporary side effects such as dizziness, headache, or nausea. These effects are generally mild and short-lived, but severe reactions are possible and should be reported to a healthcare provider immediately.

Brevibloc Premixed should be handled with care and administered under medical supervision. It is important to inform healthcare providers about any allergies or pre-existing conditions before use. Proper storage and handling procedures should be followed to ensure the integrity and effectiveness of the medication.

Brevibloc Premixed may interact with other medications, including other beta-blockers, calcium channel blockers, and certain antidepressants. It is important to disclose all current medications to a healthcare provider to avoid potential interactions. Alcohol and other substances that affect the central nervous system should be avoided while using this medication.